BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 31775679)

  • 1. Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
    Malla SB; Byrne RM; Lafarge MW; Corry SM; Fisher NC; Tsantoulis PK; Mills ML; Ridgway RA; Lannagan TRM; Najumudeen AK; Gilroy KL; Amirkhah R; Maguire SL; Mulholland EJ; Belnoue-Davis HL; Grassi E; Viviani M; Rogan E; Redmond KL; Sakhnevych S; McCooey AJ; Bull C; Hoey E; Sinevici N; Hall H; Ahmaderaghi B; Domingo E; Blake A; Richman SD; Isella C; Miller C; Bertotti A; Trusolino L; Loughrey MB; Kerr EM; Tejpar S; ; Maughan TS; Lawler M; Campbell AD; Leedham SJ; Koelzer VH; Sansom OJ; Dunne PD
    Nat Genet; 2024 Mar; 56(3):458-472. PubMed ID: 38351382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trial.
    Goh V; Mallett S; Boulter V; Glynne-Jones R; Khan S; Lessels S; Patel D; Prezzi D; Rodriguez-Justo M; Taylor SA; Beable R; Betts M; Breen DJ; Britton I; Brush J; Correa P; Dodds N; Dunlop J; Gourtsoyianni S; Griffin N; Higginson A; Lowe A; Slater A; Strugnell M; Tolan D; Zealley I; Halligan S;
    Eur Radiol; 2024 Jun; ():. PubMed ID: 38836939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Challenges and Controversies in Colorectal Carcinoma Pathologic Staging-A Practical Guide.
    Clark I; Mehreen A; Dickson PV; Shibata D; Glazer ES; Choudhury N; Jain R
    Adv Anat Pathol; 2024 Jan; 31(1):43-51. PubMed ID: 38054483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond traditional subtyping: a multilayered genomic perspective on colorectal cancer.
    Ouladan S; Orouji E
    Gut; 2024 May; ():. PubMed ID: 38749670
    [No Abstract]   [Full Text] [Related]  

  • 5. Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
    Malla SB; Byrne RM; Lafarge MW; Corry SM; Fisher NC; Tsantoulis PK; Mills ML; Ridgway RA; Lannagan TRM; Najumudeen AK; Gilroy KL; Amirkhah R; Maguire SL; Mulholland EJ; Belnoue-Davis HL; Grassi E; Viviani M; Rogan E; Redmond KL; Sakhnevych S; McCooey AJ; Bull C; Hoey E; Sinevici N; Hall H; Ahmaderaghi B; Domingo E; Blake A; Richman SD; Isella C; Miller C; Bertotti A; Trusolino L; Loughrey MB; Kerr EM; Tejpar S; ; Maughan TS; Lawler M; Campbell AD; Leedham SJ; Koelzer VH; Sansom OJ; Dunne PD
    Nat Genet; 2024 Jun; ():. PubMed ID: 38831011
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Classifiers in Skin Cancers: Challenges and Promises.
    Azimi A; Fernandez-Peñas P
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsupervised machine learning-based clustering identifies unique molecular signatures of colorectal cancer with distinct clinical outcomes.
    Singh MP; Rai S; Gupta SK; Singh NK; Srivastava S
    Genes Dis; 2023 Nov; 10(6):2270-2273. PubMed ID: 37554193
    [No Abstract]   [Full Text] [Related]  

  • 8. High Intratumoral i-tRF-Gly
    Christodoulou S; Katsaraki K; Vassiliu P; Danias N; Michalopoulos N; Tzikos G; Sideris DC; Arkadopoulos N
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management.
    Rejali L; Seifollahi Asl R; Sanjabi F; Fatemi N; Asadzadeh Aghdaei H; Saeedi Niasar M; Ketabi Moghadam P; Nazemalhosseini Mojarad E; Mini E; Nobili S
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular classification of colorectal cancer and correlation with survival.
    Mangi FH; Shaikh TA; Soria D; Waryah AM; Ujjan ID; Qureshi JN; Syed BM
    Saudi J Biol Sci; 2022 May; 29(5):3929-3936. PubMed ID: 35844384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.
    Valenzuela G; Canepa J; Simonetti C; Solo de Zaldívar L; Marcelain K; González-Montero J
    World J Clin Oncol; 2021 Nov; 12(11):1000-1008. PubMed ID: 34909395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma.
    Azcue P; Guerrero Setas D; Encío I; Ibáñez-Beroiz B; Mercado M; Vera R; Gómez-Dorronsoro ML
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer: From Genetic Landscape to Targeted Therapy.
    El Bali M; Bakkach J; Bennani Mechita M
    J Oncol; 2021; 2021():9918116. PubMed ID: 34326875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ten Hoorn S; de Back TR; Sommeijer DW; Vermeulen L
    J Natl Cancer Inst; 2022 Apr; 114(4):503-516. PubMed ID: 34077519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Two Novel Circular RNAs Deriving from
    Karousi P; Artemaki PI; Sotiropoulou CD; Christodoulou S; Scorilas A; Kontos CK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping improves prognostication of Stage 2 colorectal cancer.
    Purcell RV; Schmeier S; Lau YC; Pearson JF; Frizelle FA
    BMC Cancer; 2019 Nov; 19(1):1155. PubMed ID: 31775679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.
    Bramsen JB; Rasmussen MH; Ongen H; Mattesen TB; Ørntoft MW; Árnadóttir SS; Sandoval J; Laguna T; Vang S; Øster B; Lamy P; Madsen MR; Laurberg S; Esteller M; Dermitzakis ET; Ørntoft TF; Andersen CL
    Cell Rep; 2017 May; 19(6):1268-1280. PubMed ID: 28494874
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.